Mirum and Incyte to present zilurgisertib study results at ENDO 2026
Go back to Mirum and Incyte to present zilurgisertib study results at ENDO 2026| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 116.86 +3.05 (2.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $113.81 | 52 Week High | $118.49 | |||
| Open | $114.18 | 52 Week Low | $55.00 | |||
| Day High | $118.69 | P/E | N/A | |||
| Day Low | $113.50 | EPS | $-0.56 | |||
| Volume | 2,632,597 | |||||
| (NASDAQ: MIRM) | Delayed: 125.59 +5.13 (4.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $120.46 | 52 Week High | $ | |||
| Open | $121.58 | 52 Week Low | $ | |||
| Day High | $125.75 | P/E | N/A | |||
| Day Low | $119.98 | EPS | $ | |||
| Volume | 653,000 | |||||

